富血小板血作为一种新的添加剂对人类胚胎发育和临床结果的影响
Chang-Seop Hyun1, Mi-Ji Park1, Eun-Jeong Jang1
1Pyeongchon Maria IVF Center, Anyang, Republic of Korea.
Clinical and experimental reproductive medicine
|November 24, 2025
概括
在胚胎培养基中添加自身的富血小板血 (PRP) 显著改善了胚胎质量,并增加了复发性植入失败 (RIF) 患者的临床怀孕和植入率. 这种生育治疗显示出改善试管婴儿成功的希望.
科学领域:
- 生殖医学 生殖医学
- 胚胎学 胚胎学
- 在体外受精 (IVF)
背景情况:
- 反复植入失败 (RIF) 在辅助生殖技术中构成了重大挑战.
- 确定辅助疗法以改善试管婴儿的结果对于患者的成功至关重要.
研究的目的:
- 评估自身富血小板血 (PRP) 对RIF患者胚胎发育和临床结果的影响.
- 确定以PRP补充胚胎培养基是否可以提高胚胎质量和怀孕率.
主要方法:
- 进行了一项涉及201名RIF患者的比较研究.
- 77名患者接受了在5%的PRP (PRP组) 中培养的胚胎,而124人作为对照.
- 在胚胎移植后评估了胚胎质量和临床结果.
主要成果:
- 而PRP组显示出更高比例的优质胚胎 (在第3天至少有6个细胞).
- 临床怀孕,植入和正在进行的怀孕率在PRP组显着更高.
- 两组之间的流产率没有显著差异.
结论:
- 用自主PRP补充胚胎培养基可以提高胚胎质量.
- 补充PRP显著提高了RIF患者的植入,临床怀孕和持续怀孕率.
- 在具有挑战性的病例中,PRP代表了一种有前途的辅助疗法,可以改善试管婴儿的成功.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...


